Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoltan Janka

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|December 21, 2011
[Schizophrenia, environment and epigenetics]Anita Must, Zoltan Janka, Szatmar Horvath
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|March 20, 2012
The "blue" side of glutamatergic neurotransmission: NMDA receptor antagonists as possible novel therapeutics for major depressionReka Szakacs, Zoltan Janka, Janos Kalman
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|September 19, 2012
Marking the markers of Alzheimer's: too good to diagnose, too bad to use?Zita Olah, Magdolna Pakaski, Zoltan Janka, et al.
Frontiers in Psychology|October 18, 2013
The Iowa Gambling Task in depression - what have we learned about sub-optimal decision-making strategies?Anita Must, Szatmar Horvath, Viola L Nemeth, et al.
Frontiers in Psychology|December 7, 2016
The Effect of Emotion and Reward Contingencies on Relational Memory in Major Depression: An Eye-Movement Study with Follow-UpViola L Nemeth, Gergo Csete, Gergely Drotos, et al.
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|October 22, 2010
[9-hydroxy-risperidone (9OHRIS) prevents stress-induced β-actin overexpression in rat hippocampus]Sara Kalman, Magdolna Pakaski, Szabina Szucs, et al.
Journal of Psychopharmacology (Oxford, England)|October 20, 2006
The other face of depression, reduced positive affect: the role of catecholamines in causation and cureDavid Nutt, Koen Demyttenaere, Zoltan Janka, et al.
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|March 20, 2012
[Achetylcholinesterase (AChE) inhibition and serum lipokines in Alzheimer's disease: friend or foe?]Janos Kovacs, Magdolna Pakaski, Anna Juhasz, et al.
Ecotoxicology and Environmental Safety|June 13, 2017
Novel in vivo experimental viability assays with high sensitivity and throughput capacity using a bdelloid rotiferZita Olah, Ashley I Bush, David Aleksza, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 23, 2003
Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophreniaIstvan Bitter, Martin R K Dossenbach, Shlomo Brook, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|December 21, 2011
[Schizophrenia, environment and epigenetics]Anita Must, Zoltan Janka, Szatmar Horvath
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|March 20, 2012
The "blue" side of glutamatergic neurotransmission: NMDA receptor antagonists as possible novel therapeutics for major depressionReka Szakacs, Zoltan Janka, Janos Kalman
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|September 19, 2012
Marking the markers of Alzheimer's: too good to diagnose, too bad to use?Zita Olah, Magdolna Pakaski, Zoltan Janka, et al.
Frontiers in Psychology|October 18, 2013
The Iowa Gambling Task in depression - what have we learned about sub-optimal decision-making strategies?Anita Must, Szatmar Horvath, Viola L Nemeth, et al.
Frontiers in Psychology|December 7, 2016
The Effect of Emotion and Reward Contingencies on Relational Memory in Major Depression: An Eye-Movement Study with Follow-UpViola L Nemeth, Gergo Csete, Gergely Drotos, et al.
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|October 22, 2010
[9-hydroxy-risperidone (9OHRIS) prevents stress-induced β-actin overexpression in rat hippocampus]Sara Kalman, Magdolna Pakaski, Szabina Szucs, et al.
Journal of Psychopharmacology (Oxford, England)|October 20, 2006
The other face of depression, reduced positive affect: the role of catecholamines in causation and cureDavid Nutt, Koen Demyttenaere, Zoltan Janka, et al.
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|March 20, 2012
[Achetylcholinesterase (AChE) inhibition and serum lipokines in Alzheimer's disease: friend or foe?]Janos Kovacs, Magdolna Pakaski, Anna Juhasz, et al.
Ecotoxicology and Environmental Safety|June 13, 2017
Novel in vivo experimental viability assays with high sensitivity and throughput capacity using a bdelloid rotiferZita Olah, Ashley I Bush, David Aleksza, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 23, 2003
Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophreniaIstvan Bitter, Martin R K Dossenbach, Shlomo Brook, et al.
Pageof 1